On Dec. 10, 2021, the World Health Organization announced interim recommendations for the use of the Janssen Ad26.COV2.S…
On Dec. 10, 2021, Moderna announced an amendment to its existing contract with Gavi, the Vaccine Alliance, to…
On Dec. 9, 2021, CytoDyn announced that it had submitted a Phase 3, randomized, double blind, placebo controlled…
On Dec. 9, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had expanded…
On Dec. 9, 2021, Moderna announced the launch of its Artificial Intelligence Academy, an innovative initiative that will…
On Dec. 8, 2021, Pfizer and BioNTech announced results from an initial laboratory study demonstrating that serum antibodies…
On Dec. 8, 2021, PerkinElmer announced the research use only launch of the NEXTFLEXﾮ Variant-Seqﾙ SARS-CoV-2 Kit v2…
On Dec. 8, 2021, in a large-scale study of people from diverse ancestries, researchers narrowed down the number…
On Dec. 8, 2021, the U.S. Food and Drug Administration issued an emergency use authorization for AstraZenecaﾒs Evusheld…
On Dec. 7, 2021, Arbutus Biopharma, X-Chem, and Proteros announced that Arbutus had identified several molecules that inhibit…
On Dec. 7, 2021, Rockefeller University scientists announced a study had demonstrated the therapeutic potential of an unusual…
On Dec. 7, 2021, the Centers for Disease Control and Prevention announced that it had awarded $22 million…
On Dec. 6, 2021, the USAID announced the foundation of a new whole-of-government effort, the Initiative for Global…
On Dec. 6, 2021, the World Health Organization Guideline Development Group of international experts announced in the BMJ…
On Dec. 6, 2021, Roche announced that the European Medicines Agencyﾒs Committee for Medicinal Products for Human Use…
On Dec. 5, 2021, Sorrento Therapeutics announced the peer-reviewed publication of a series of novel SARS-CoV-2 MPro inhibitors…
On Dec. 5, 2021, Johnson & Johnson announced preliminary results from an independent study, including a subset of…
On Dec. 5, 2021, Roche announced that its planned to launch the SARS-CoV-2 & Flu A/B Rapid Antigen…
On Dec. 3, 2021, Genomics England has announced its vision for a pilot research project to examine the…
On Dec. 3, 2021, Gavi, the Vaccine Alliance, approved a new malaria vaccination programme to support the introduction,…
On Dec. 3, 2021, Roche and TIB Molbiol announced they had added three additional Research Use Only test…
On Dec. 3, 2021, a report from the U.S. Department of Health and Human Services (HHS) found that…
On Dec. 2, 2021, National Resilience and Harvard University announed they had established a five-year research and development…
On Dec. 2, 2021, researchers at the National Eye Institute (NEI) announced they had identified, isolated, and characterized…
On Dec. 1, 2021, SIGA Technologies announced that Health Canada had approved oral TPOXX (tecovirimat) as an extraordinary…
On Dec. 1, 2021, Moderna announced a revised supply agreement with the UK government for up to 60…
On Dec. 1, 2021, T2 Biosystems announced that its T2SARS-CoV-2 Panel detected the Omicron COVID-19 variant (B.1.1.529). The…
On Dec. 1, 2021, the California and San Francisco Departments of Public Health confirmed that a recent case…
On Dec. 1, 2021, Fulgent Genetics confirmed that the Companyﾒs RT-PCR test for SARS-CoV-2, the virus that causes…
On Nov. 30, 2021, Inovio Pharma announced the company was rapidly moving to evaluate its COVID-19 DNA vaccine…